Name | 4-[3-(3-tert-butyl-4-pyrrolidin-1-ylphenyl)-4-(2-hydroxyethoxy)phenyl]benzoic acid |
---|---|
Synonyms |
4'-(2-Hydroxyethoxy)-3''-(2-methyl-2-propanyl)-4''-(1-pyrrolidinyl)-1,1':3',1''-terphenyl-4-carboxylic acid
[1,1':3',1''-Terphenyl]-4-carboxylic acid, 3''-(1,1-dimethylethyl)-4'-(2-hydroxyethoxy)-4''-(1-pyrrolidinyl)- Trifarotene CD5789 UNII-0J8RN2W0HK |
Description | Trifarotene is a retinoic acid receptor (RAR) agonist with Kdapp of 2, 15 and 500 nM for RARγ, RARβ and RARα, respectively. |
---|---|
Related Catalog | |
Target |
Kdapp: 2 nM (RARγ), 15 nM (RARβ), 500 nM (RARα)[1] |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 641.9±55.0 °C at 760 mmHg |
Molecular Formula | C29H33NO4 |
Molecular Weight | 459.577 |
Flash Point | 342.0±31.5 °C |
Exact Mass | 459.240967 |
PSA | 70.00000 |
LogP | 6.27 |
Vapour Pressure | 0.0±2.0 mmHg at 25°C |
Index of Refraction | 1.599 |
Storage condition | 2-8℃ |